Allspring Global Investments Holdings LLC Sells 141,433 Shares of Zepp Health Corporation Sponsored ADR $ZEPP

Key Points

• Allspring Global sold 141,433 shares of Zepp Health in Q4, cutting its stake by 68.1% to 66,351 shares (about 0.46% of the company) valued at roughly $1.79 million.
• Institutional ownership is significant at about 52.61%, and several other funds (including Public Employees Retirement System of Ohio, Oasis Management, Centiva Capital, Ariose Capital and Harvest Fund Management) recently initiated or added positions.
• Analyst and market context: Weiss Ratings reaffirmed a “sell (d-)” while the stock’s consensus is a “Hold” with an average price target of $64.37; shares opened at $11.65, trade well below their 200-day average, and the company has a market cap near $169M.

Allspring Global Investments Holdings LLC lowered its position in shares of Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Free Report) by 68.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 66,351 shares of the company's stock after selling 141,433 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.46% of Zepp Health worth $1,787,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the company. Public Employees Retirement System of Ohio bought a new stake in Zepp Health during the third quarter valued at $43,000. Oasis Management Co Ltd. bought a new stake in Zepp Health during the third quarter valued at $276,000. Centiva Capital LP bought a new stake in Zepp Health during the third quarter valued at $538,000. Ariose Capital Management Ltd bought a new stake in Zepp Health during the third quarter valued at $1,269,000. Finally, Harvest Fund Management Co. Ltd bought a new stake in Zepp Health during the third quarter valued at $1,895,000. Institutional investors own 52.61% of the company's stock.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Zepp Health in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $64.37.

Zepp Health Price Performance

Shares of NYSE ZEPP opened at $11.65 on Thursday. The firm's 50-day moving average price is $17.97 and its 200-day moving average price is $28.45. Zepp Health Corporation Sponsored ADR has a 1-year low of $2.13 and a 1-year high of $61.85. The firm has a market capitalization of $168.97 million, a P/E ratio of -4.64 and a beta of 1.76. The company has a current ratio of 1.02, a quick ratio of 0.77 and a debt-to-equity ratio of 0.28.

Zepp Health Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health's integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health's offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.

Want to see what other hedge funds are holding ZEPP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.